Results 11 to 20 of about 8,755 (175)

Lassa Virus Treatment Options

open access: yesMicroorganisms, 2021
Lassa fever causes an approximate 5000 to 10,000 deaths annually in West Africa and cases have been imported into Europe and the Americas, challenging public health. Although Lassa virus was first described over 5 decades ago in 1969, no treatments or vaccines have been approved to treat or prevent infection.
Frederick Hansen   +3 more
openaire   +3 more sources

Characterization of Lassa Virus Cell Entry and Neutralization with Lassa Virus Pseudoparticles [PDF]

open access: yesJournal of Virology, 2009
ABSTRACT The cell entry and humoral immune response of the human pathogen Lassa virus (LV), a biosafety level 4 (BSL4) Old World arenavirus, are not well characterized. LV pseudoparticles (LVpp) are a surrogate model system that has been used to decipher factors and routes involved in LV cell entry under BSL2 conditions.
François-Loïc, Cosset   +8 more
openaire   +4 more sources

New Hosts of The Lassa Virus [PDF]

open access: yesScientific Reports, 2016
Abstract Lassa virus (LASV) causes a deadly haemorrhagic fever in humans, killing several thousand people in West Africa annually. For 40 years, the Natal multimammate rat, Mastomys natalensis , has been assumed to be the sole host of LASV.
Olayemi, Ayodeji   +19 more
openaire   +3 more sources

Phylogenetic and Mutational Analysis of Lassa Virus Strains Isolated in Nigeria: Proposal for an In Silico Study

open access: yesJMIR Research Protocols, 2021
BackgroundIn 2018, the total number of Lassa fever cases in Nigeria was significantly higher than that observed in previous years. Hence, studies had attempted to determine the underlying cause. However, reports using phylogenetic methods to analyze this
Kolawole, Daniel   +2 more
doaj   +1 more source

Replicon System for Lassa Virus [PDF]

open access: yesJournal of Virology, 2004
ABSTRACT Lassa virus is endemic to West Africa and causes hemorrhagic fever in humans. To facilitate the functional analysis of this virus, a replicon system was developed based on Lassa virus strain AV. Genomic and antigenomic minigenomes (MG) were constructed consisting of the intergenic region of S RNA and a reporter gene (
Meike, Hass   +4 more
openaire   +2 more sources

Pathogenesis of Lassa Fever

open access: yesViruses, 2012
Lassa virus, an Old World arenavirus (family Arenaviridae), is the etiological agent of Lassa fever, a severe human disease that is reported in more than 100,000 patients annually in the endemic regions of West Africa with mortality rates for ...
David H. Walker, Nadezhda E. Yun
doaj   +1 more source

Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2012
BACKGROUND: Lassa fever is a viral hemorrhagic fever endemic in West Africa. However, none of the hospitals in the endemic areas of Nigeria has the capacity to perform Lassa virus diagnostics.
Danny A Asogun   +29 more
doaj   +1 more source

An overview of Lassa fever

open access: yesWikiJournal of Medicine, 2019
Lassa fever is a viral hemorrhagic fever caused by Lassa virus (Lassa mammarenavirus), a negative-sense single-stranded RNA virus of the Arenaviridae family. In most cases Lassa virus infection is asymptomatic (presenting no symptom). When symptomatic it
Abdulmutalab Musa
doaj   +1 more source

Development of a new vaccine for the prevention of Lassa fever.

open access: yesPLoS Medicine, 2005
BACKGROUND: Recent importation of Lassa fever into Germany, the Netherlands, the United Kingdom, and the United States by travelers on commercial airlines from Africa underscores the public health challenge of emerging viruses.
Thomas W Geisbert   +15 more
doaj   +2 more sources

Use of Favipiravir to Treat Lassa Virus Infection in Macaques

open access: yesEmerging Infectious Diseases, 2018
Lassa virus, the cause of Lassa fever in humans, is endemic to West Africa. Treatment of Lassa fever is primarily supportive, although ribavirin has shown limited efficacy if administered early during infection.
Kyle Rosenke   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy